Skip to main content

BioDelivery Sciences International, Inc. (BDSI)

NASDAQ: BDSI · IEX Real-Time Price · USD
4.05 -0.09 (-2.17%)
Oct 25, 2021 4:00 PM EDT - Market closed
Market Cap403.76M
Revenue (ttm)164.07M
Net Income (ttm)33.88M
Shares Out98.79M
EPS (ttm)0.32
PE Ratio12.58
Forward PE10.35
Dividendn/a
Ex-Dividend Daten/a
Volume628,380
Open4.13
Previous Close4.14
Day's Range4.05 - 4.14
52-Week Range3.04 - 4.99
Beta0.73
AnalystsStrong Buy
Price Target7.46 (+84.2%)
Est. Earnings DateNov 3, 2021

About BDSI

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and...

IndustryPharmaceuticals
Founded1997
CEOJeffrey Bailey
Employees176
Stock ExchangeNASDAQ
Ticker SymbolBDSI
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for BDSI stock is "Strong Buy." The 12-month stock price forecast is 7.46, which is an increase of 84.20% from the latest price.

Price Target
$7.46
(84.20% upside)
Analyst Consensus: Strong Buy

News

BioDelivery Sciences International (BDSI) is a Top-Ranked Momentum Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

1 month ago - Zacks Investment Research

4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507%

Biotech Penny Stocks Surge As Sector Reverses Course The post 4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507% appeared first on Penny Stocks to Buy, Picks, News and Information | ...

Other symbols:ENVBEYEGOPGN
1 month ago - PennyStocks

Best Reddit Penny Stocks To Buy Now? 5 For Your List In September 2021

Which Reddit penny stocks are on your watchlist right now? The post Best Reddit Penny Stocks To Buy Now?

Other symbols:CYRNIDEXOPKSONM
1 month ago - PennyStocks

BioDelivery Sciences to Exhibit Three Scientific Posters Comparing BELBUCA® to Oxycodone at the PAINWeek 2021 Conference

RALEIGH, N.C., Sept. 07, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with chronic conditions...

1 month ago - GlobeNewsWire

BioDelivery (BDSI) Up 3.2% Since Last Earnings Report: Can It Continue?

BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

BioDelivery Sciences to Participate in Upcoming Virtual Investor Conferences

RALEIGH, N.C., Sept. 03, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious an...

1 month ago - GlobeNewsWire

Top Penny Stocks You Need to Know About Right Now

Are these top penny stocks on your small-caps watchlist The post Top Penny Stocks You Need to Know About Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:CTXREYEGSENS
2 months ago - PennyStocks

BioDelivery Sciences International (BDSI) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

2 months ago - Zacks Investment Research

BioDelivery Sciences Reports Mixed Q2 Earnings, Sees FY21 Belbuca Sales At Lower End Of Guidance Range

BioDelivery Sciences International Inc (NASDAQ: BDSI) has reported Q2 sales of $41.4 million, + 13.3% Y/Y, missing the consensus of $42.4 million.  Sales growth was driven by all-time high Belbuca sales...

2 months ago - Benzinga

BioDelivery Sciences International (BDSI) Beats Q2 Earnings Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of 80.00% and -1.39%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

BioDelivery Sciences Reports Second Quarter 2021 Results

Total Company Net Revenue of $41.4 Million Driven by BELBUCA® All-Time High TRx Market Share

2 months ago - GlobeNewsWire

BioDelivery Sciences Announces Agreement to Acquire U.S. and Canadian Rights to FDA-approved ELYXYB™ for the Acute Tr...

The only FDA-approved, ready-to-use oral solution for the acute treatment of migraine with or without aura in adults

2 months ago - GlobeNewsWire

BioDelivery Sciences International (BDSI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

This Undervalued Biotech Penny Stock Could Soon Double

A handful of trends might drive BioDelivery Sciences' share price growth.

3 months ago - The Motley Fool

Best Reddit Penny Stocks to Buy Now? 7 for Your July Small-Caps List

Are these Reddit penny stocks the best 7 to watch in July 2021? The post Best Reddit Penny Stocks to Buy Now?

3 months ago - PennyStocks

BioDelivery Sciences International (BDSI) Misses Q1 Earnings Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of -28.57% and 0.07%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

BioDelivery Sciences Reports First Quarter 2021 Results

Total Company Net Revenue of $41 Million, an Increase of 7% versus Prior Year Net Income of $5.2 Million, EBITDA Margin of 22% and Operating Cash Generation of $11 Million Conference Call and Webcast Sc...

5 months ago - GlobeNewsWire

BioDelivery Sciences International (BDSI) Earnings Expected to Grow: Should You Buy?

BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

5 Health Care Stocks Trading with Low Price-Earnings Ratios

As of April 21, the GuruFocus All-in-One Screener, a Premium feature, found that the following guru-owned utilities have low price-earnings ratios. While some of them are great value investments, others...

Other symbols:CODXKMDASURFVMD
6 months ago - GuruFocus

BioDelivery Sciences to Report First Quarter 2021 Financial Results on May 6, 2021

RALEIGH, N.C., April 20, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious an...

6 months ago - GlobeNewsWire

3 Magic Formula Health Care Stock Picks

If you want to enhance your likelihood to beat the market, one method is to select stocks that rank highly according to the "Magic Formula" criteria.

Other symbols:BPMCFLGT
6 months ago - GuruFocus

BioDelivery (BDSI) Down 12.8% Since Last Earnings Report: Can It Rebound?

BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock?

6 months ago - Zacks Investment Research

Moving Average Crossover Alert: BioDelivery Sciences (BDSI)

BioDelivery Sciences (BDSI) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

6 months ago - Zacks Investment Research

Well-Known Companies Highlight Stocks to Buy Under $10 With Huge Potential

While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Other symbols:ADTSWNTRUEWTRH
7 months ago - 24/7 Wall Street

BioDelivery (BDSI) Beats Q4 Earnings Estimates, Stock Up

BioDelivery's (BDSI) strong Belubca sales drive the top line. Symproic further boosts revenues.

7 months ago - Zacks Investment Research